The STD Basic panel is a curated selection of tests aimed at detecting some of the most common sexually transmitted diseases (STDs). These tests employ various laboratory techniques to identify the presence of specific pathogens or the body's immune response to them. By providing insights into an individual's sexual health status, this panel plays a pivotal role in early detection, treatment, and prevention of further transmission of these infections.

 The STD Comprehensive panel offers a broad overview of an individual's sexual health by screening for several prevalent sexually transmitted diseases. This comprehensive approach ensures that both bacterial and viral infections are tested for, providing a detailed picture of potential risks and existing infections, many of which may be asymptomatic.

 The STD Urinary Tract Infection Panel is a targeted diagnostic tool designed to identify sexually transmitted infections (STIs) such as Chlamydia and Gonorrhea, alongside assessing overall urinary tract health through a Urinalysis Complete test. This panel facilitates the early detection of common STIs and urinary tract infections (UTIs), allowing for timely treatment and management.

The Lymphogranuloma Venereum (LGV) Differentiation Antibody Panel uses micro-immunofluorescence (MIF) to measure IgG, IgA, and IgM antibodies to Chlamydia trachomatis (LGV L1 and non-LGV D–K) and related Chlamydiaspecies (C. pneumoniae and C. psittaci). It helps differentiate antibody patterns consistent with LGV versus other chlamydial exposures when cross-reactivity may complicate interpretation.